Go to the list of all blogs
Allana's Avatar
published in Blogs
Mar 27, 2019
Health insurer Centene to buy smaller rival WellCare for $15.27 billion - Reuters

Health insurer Centene to buy smaller rival WellCare for $15.27 billion - Reuters

U.S. health insurer Centene Corp confirmed on Wednesday that it would buy WellCare Health Plans Inc in a cash-and-stock deal to bulk up its government-backed healthcare business, valuing its smaller rival at $15.27 billion.

Read more...

Related Ticker: HHCAX

Contributor

Allana's AvatarAllana|Expert

Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.

Notable companies

The most notable companies in this group are Electronic Arts (NASDAQ:EA).

Industry description

The investment seeks long-term capital appreciation. The fund seeks to achieve its investment objective by primarily investing in equity, debt, and/or derivative securities of companies that the Adviser expects to benefit from an event catalyst. It may invest significantly in the common stock of and other interests (e.g., warrants) in special purpose acquisition companies or similar special purpose entities that pool funds to seek potential acquisition opportunities (collectively, “SPACs”). The fund may invest in SPACs for a variety of investment purposes, including to achieve income. It is non-diversified.

Market Cap

The average market capitalization across the NexPoint Event Driven A MF is 8.5B. The market cap for tickers in the group ranges from 2.05B to 52.93B. EA holds the highest valuation in this group at 52.93B. The lowest valued company is SEM at 2.05B.

Volume

The average weekly volume growth across all stocks in the NexPoint Event Driven A MF was 28%. For the same stocks of the MF, the average monthly volume growth was -21% and the average quarterly volume growth was -9%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 39
P/E Growth Rating: 50
Price Growth Rating: 50
SMR Rating: 76
Profit Risk Rating: 84
Seasonality Score: -38 (-100 ... +100)
View a ticker or compare two or three
Ask AI
VS
Compare
VS
Compare
Interact to see
Advertisement
A.I.Advisor
published price charts
View AI-Driven Trading for HHCAX
A.I. Advisor
published General Information

General Information

Category Trading

Profile
Details
Category
Event Driven
Address
NEXPOINT FUNDS I300 CRESCENT COURT, SUITE 700Dallas
Phone
N/A
Web
www.highlandfunds.com
Interact to see
Advertisement

Why Did Hims & Hers Health (HIMS) Stock Move Up +43.85% Today?

HIMS shares surged approximately +43.85% in premarket trading on Monday, March 9, 2026, rising from a prior close of $15.74 to around $22.80. Primary catalyst: Novo Nordisk officially ended its patent infringement lawsuit against Hims & Hers and announced a landmark partnership to distribute branded Wegovy through the Hims platform at $599/month.
HIMS#PharmaceuticalsGeneric
Arthur Evans, expert
Mar 09, 2026

Why Did Xenon Pharmaceuticals (XENE) Stock Move Up +45.93% Today?

XENE shares surged approximately +45.93% in premarket trading on March 9, 2026, one of the largest single-session moves in the company's history. The primary catalyst: Xenon announced positive topline Phase 3 X-TOLE2 results for its lead drug candidate azetukalner in focal onset seizures (FOS), meeting the primary endpoint with overwhelming statistical significance.
XENE#Biotechnology
Arthur Evans, expert
Mar 09, 2026

Why Did Olema Oncology (OLMA) Stock Fall -41% Today?

Shares of OLMA dropped approximately 41% in Monday's session, one of the steepest single-day declines in the company's history. The primary catalyst was Roche's Phase 3 persevERA trial failure — a late-stage study of giredestrant, a closely competing selective estrogen receptor degrader (SERD), which missed its primary endpoint of statistically significant improvement in progression-free survival.
OLMA#Biotechnology
Arthur Evans, expert
Mar 09, 2026

Why Did Relmada Therapeutics (RLMD) Stock Move Up +40% Today?

RLMD shares surged approximately +40% at the open on March 9, 2026, rising from a prior close of $4.45 to approximately $6.23, driven by a major clinical trial readout. The primary catalyst was the announcement of 12-month interim data from the Phase 2 trial of NDV-01, Relmada's lead oncology candidate, in patients with high-risk non-muscle invasive bladder cancer (NMIBC) — results that significantly exceeded historical benchmarks.
RLMD#Biotechnology
Arthur Evans, expert
Mar 09, 2026

Why Did Circle Internet Group (CRCL) Stock Move Up +8.66% Today?

CRCL surged +8.66% on Monday, March 9, 2026, rising from a prior close of $101.94 to trade at $110.77 intraday. The primary catalyst is a landmark stablecoin milestone: Circle's USDC overtook Tether as the dominant stablecoin by transfer volume, accounting for approximately 70% of all stablecoin transfer activity as total stablecoin transfers hit $1.8 trillion in February.
CRCL#InvestmentBanksBrokers
Arthur Evans, expert
Mar 09, 2026

Why Did Carnival Corporation & plc (CCL) Stock Move Down -7.60% Today?

Carnival Corporation (CCL) shares fell approximately -7.60% in Monday's session, dropping from a Friday close of $25.79 to around $23.83. The primary catalyst is a broad market sell-off driven by intensifying recession fears, with the S&P 500 and consumer discretionary names bearing the brunt of the pressure.
CCL#ConsumerSundries
Arthur Evans, expert
Mar 09, 2026

Why Did Bloom Energy (BE) Stock Move Up +10.30% Today?

Shares of Bloom Energy (BE) are surging approximately +10.30% in Monday's session, rebounding sharply from a steep -15.50% selloff on Friday, March 6, 2026. Friday's decline was triggered by an Oracle-OpenAI data center project update that spooked energy infrastructure investors; Monday's move reflects aggressive dip-buying and a sentiment reset.
BE#ElectricalProducts
Arthur Evans, expert
Mar 09, 2026

The Great Software Squeeze: How Short Sellers Just Fueled a Historic Snapback Rally

IGV has rallied about 8–9% in the last 6 trading days, while SOXX has dropped about 8%, giving software a +16.6 percentage‑point edge—the largest 6‑day software‑over‑semi outperformance ever.[barchart]​ This comes right after software lagged semis by almost −15 percentage points into late January, the widest gap since 2008, and as hedge‑fund short exposure to U.S. software and services hit a record ~3.8% of market cap.
IGVSOXXMSFT#Technology#ComputerCommunications
Alicia, beginner
Mar 09, 2026

Why Crude’s Rally Vanished on March 9 and What Trump Said

Crude’s explosive war‑driven spike faded on March 9 because the market suddenly started to price less extreme, shorter‑lived supply risk and more policy intervention, not a multi‑month shortage. WTI, which had briefly traded above 115–120 dollars on Iran‑war headlines and Strait of Hormuz fears, slid back toward the high‑80s as traders digested G7 reserve‑release talk, Trump’s comments about a “brief” war, and the reality that prices had run far ahead of fundamentals.
WTIXLEXOM#OilGasProduction#Energy#IntegratedOil
Mar 10, 2026

Why Did Arq, Inc. (ARQ) Stock Fall -27.50% Today?

Shares of ARQ plunged approximately 27.50% in premarket trading on March 10, 2026, from a prior close of $3.20 to roughly $2.32. The primary catalyst was a deeply disappointing Q4 2025 earnings report, which revealed a net loss of $50.0 million for the quarter versus a net loss of $1.3 million in Q4 2024.
ARQ#IndustrialSpecialties
Arthur Evans, expert
Mar 10, 2026

Why Is FreightCar America (RAIL) Stock Down -15% Today?

RAIL shares fell approximately 15% in premarket trading on March 10, 2026, following a steep after-hours reaction to disappointing Q4 2025 earnings results released after the close on March 9. The primary catalyst was a significant revenue miss: Q4 revenue came in at $125.6 million, well below consensus estimates near $144–$160 million, representing an 8.8% year-over-year decline.
RAIL#Railroads
Arthur Evans, expert
Mar 10, 2026

Why Did Zevra Therapeutics (ZVRA) Stock Move Up +17.86% Today?

ZVRA shares surged approximately +17.86% on March 10, 2026, driven by a blockbuster Q4 and full-year 2025 earnings report released before the market open. Primary catalyst: Q4 2025 EPS of $0.19 crushed the consensus estimate of $0.05 — a 280% beat — while revenue of $34.1 million exceeded forecasts by 21.57%.
ZVRA#Biotechnology
Arthur Evans, expert
Mar 10, 2026

Why Is Lumentum Holdings (LITE) Stock Up +14.73% Today?

LITE surged +14.73% on Monday, March 9, 2026, closing at $640.69 versus a prior close of $558.44 on March 6. The primary catalyst was the landmark $2 billion strategic investment by NVIDIA announced March 2, with the market continuing to price in its full implications following a brief post-announcement pullback.
LITE#TelecommunicationsEquipment
Arthur Evans, expert
Mar 10, 2026

Why Did BioNTech SE (BNTX) Stock Fall -22% Today?

Shares of BNTX fell approximately 22% on Tuesday, March 10, 2026, following a dual shock of disappointing full-year guidance and a surprise leadership upheaval. The primary catalyst was BioNTech's Q4 2025 earnings report, which included a 2026 revenue outlook of €2.0–€2.3 billion — well below analyst consensus and signaling continued pressure from declining COVID-19 vaccine demand.
BNTX#Biotechnology
Arthur Evans, expert
Mar 10, 2026

Why Is Centene Corporation (CNC) Stock Down -10% Today?

CNC shares fell approximately 10% during Tuesday's session, extending a prolonged selloff in the managed care sector. The primary catalyst is intensifying investor concern over federal Medicaid and ACA funding cuts tied to the "One Big Beautiful Bill Act" (OBBBA), which threatens to shrink the government-sponsored insurance pools that Centene depends on for the majority of its revenue.
CNC#ManagedHealthCare
Arthur Evans, expert
Mar 10, 2026

The Energy Shift: Why I Believe Oil, Gas, and Materials Could Lead the Next Market Rotation

Technology recently peaked near 35% of the S&P 500 and has slipped over the last year, while Energy plus Materials remain near historically low combined weight at roughly 6%, which suggests the gap is still unusually wide.
XOMCVXCOPSLBHAL#IntegratedOil#OilGasProduction#OilfieldServicesEquipment
Mar 10, 2026

Retail Rules the Dips: How Individual Investors Became the Market’s Shock Absorber

Average daily equity purchases by retail investors on S&P 500 down days in 2026 are at the highest level on record, running about 100% above the peak intensity seen during the 2021 meme‑stock boom.
SPYQQQIWM#LargeBlend#LargeGrowth#SmallBlend
Mar 10, 2026

Palantir (PLTR) at a Crossroads: Strong Bounce, Tough Resistance

Over the past two weeks, PLTR has climbed from roughly the high‑130s to the mid‑150s, a gain of about 12–14%, with a series of strong up days between March 2 and March 6.
PLTR#ComputerCommunications
Mar 10, 2026

Why Is AeroVironment (AVAV) Stock Down -10% Today?

AVAV shares dropped approximately 10% in premarket trading on March 11, 2026, following a disappointing Q3 fiscal 2026 earnings report released after the prior session's close. Q3 revenue of $408.0 million came in far below analyst consensus of approximately $475–$488 million, representing a massive top-line miss.
AVAV#AerospaceDefense
Arthur Evans, expert
Mar 11, 2026

Why Is Kosmos Energy (KOS) Stock Down -20.31% Today?

KOS shares are down approximately 20% in premarket trading on March 11, 2026, having shed roughly 20.31% across the last two sessions (Tuesday close and premarket Wednesday). The primary catalyst is Kosmos Energy's announcement of a massive $185.25 million public equity offering priced at $1.90 per share — a steep discount to recent trading levels.
KOS#OilGasProduction
Arthur Evans, expert
Mar 11, 2026